Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis
Ther Adv Psychopharmacol. 2024 Jun 2;14:20451253241257062. doi: 10.1177/20451253241257062. eCollection 2024. ABSTRACT BACKGROUND: Long-acting injectable antipsychotics (LAIs) have advantages over oral antipsychotics (OAPs) in preventing relapse …